APPLICATION
BLA761473
TYPE
BLA
ORIGINAL APPROVAL
2025-12-18
LATEST ACTION
2025-12-18
ROUTE
INTRAVITREAL
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription
Products
NUFYMCOPrescription
RANIBIZUMAB-LEYK 6MG/ML · INJECTION
NUFYMCOPrescription
RANIBIZUMAB-LEYK 10MG/ML · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.